Following his successful 22 year career with the FBI where he led the Bureau’s Asia Cyber Counterintelligence Investigations, Todd was selected as the President and CEO of the Pharmaceutical Security Institute. Focusing on the collection, analysis and dissemination of information documenting the extent of international pharmaceutical crimes, the Institute has become a trusted source of information concerning unsafe medicines. It works closely with the security directors and quality control experts from thirty-seven pharmaceutical manufacturers. Its reports are regularly shared with global enforcement agencies including the World Customs Organization and INTERPOL. Likewise, its annual Situation Report is shared with drug regulatory agencies including the World Health Organization.